Universal Health Services (UHS)

• Market cap: $11.5B
• 1 day: 3.02%
• 5 days: 5.71%
• 1 month: -5.76%
• 3 months: -6.46%
• 6 months: -14.67%
• Year to date: -1.45%
• 1 year: 3.90%
• 5 years: 67.54%
• 10 years: 51.41%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.

Employees: 99,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

79% more call options, than puts

Call options by funds: $63.7M | Put options by funds: $35.6M

2.89% more ownership

Funds ownership: 88.88% [Q3] → 91.77% (+2.89%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

9% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 107

10% less repeat investments, than reductions

Existing positions increased: 200 | Existing positions reduced: 221

3% less funds holding

Funds holding: 613 [Q3] → 594 (-19) [Q4]

20% less capital invested

Capital invested by funds: $12.1B [Q3] → $9.67B (-$2.42B) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $200 13% upside
• Avg. target: $219 23% upside
• High target: $257 45% upside

8 analyst ratings

• positive: 3 38%
• neutral: 5 63%
• negative: 0 0%

RBC Capital Ben Hendrix 31% 1-year accuracy 22 / 70 met price target	14% upside $201	Sector Perform Maintained	30 Apr 2025
Barclays Andrew Mok 35% 1-year accuracy 21 / 60 met price target	45% upside $257	Overweight Maintained	29 Apr 2025
Baird Michael Ha 43% 1-year accuracy 10 / 23 met price target	27% upside $224	Neutral Downgraded	15 Apr 2025
Guggenheim Jason Cassorla 21% 1-year accuracy 3 / 14 met price target	17% upside $208	Buy Initiated	9 Apr 2025
Morgan Stanley Craig Hettenbach 14% 1-year accuracy 1 / 7 met price target	13% upside $200	Equal-Weight Initiated	26 Mar 2025